Earnings NewsHealthcareRepare Therapeutics GAAP EPS of -$0.70 beats by $0.02, revenue of $6.88M beats by $3.6MMar. 01, 2022 4:54 PM ETRepare Therapeutics Inc. (RPTX)By: Gaurav Batavia, SA News Editor Repare Therapeutics press release (NASDAQ:RPTX): Q4 GAAP EPS of -$0.70 beats by $0.02. Revenue of $6.88M (+4814.3% Y/Y) beats by $3.6M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsBitcoin rally bodes well for miners’ profit prospectsU.S. makes COP28 splash with new methane rule, $3B pledge to help countries cut emissionsPlug Power surges to top industrial gainer of week, Kanzhun sees No. 1 loser tagWeight loss drugs seen providing a boost to apparel stocks - StifelGrand Theft Auto should be a 'major catalyst' for Take Two. Wall Street is salivating.See More »About RPTXSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgRPTX--Repare Therapeutics Inc.VNDA--Vanda Pharmaceuticals Inc.AEON--AEON Biopharma, Inc.OVID--Ovid Therapeutics Inc.MESO--Mesoblast LimitedCompareTrending AnalysisTrending News